Incorporation of an Isohexide Subunit Improves the Drug-like Properties of Bioactive Compounds

被引:2
|
作者
Knapp, Spencer [1 ]
Dresel, Mark J. [1 ]
Sidduri, Achyutharao [1 ,2 ]
机构
[1] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA
[2] Aunova Medchem LLC, West Orange, NJ 07052 USA
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2023年 / 14卷 / 02期
基金
美国国家卫生研究院;
关键词
Isosorbide; isoidide; Mitsunobu; solubility; permeability; EGFR; alpha4; integrin; isosteres; DIANHYDROHEXITOLE-BASED BENZAMIDINES; BIOLOGICAL EVALUATION; MITSUNOBU REACTION; ISOSORBIDE; DERIVATIVES; INHIBITORS; DESIGN; IDENTIFICATION; POTENT; POLYMERIZATION;
D O I
10.1021/acsmedchemlett.2c00476
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
An enhanced ability to pre-engineer favorable drug-likeness qualities into bioactive molecules would focus and streamline the drug development process. We find that phenols, carboxylic acids, and a purine react with isosorbide ("GRAS" designated) under Mitsunobu coupling conditions to deliver the isoidide conjugates selectively and efficiently. Such conjugates show improved solubility and permeability properties compared with the bare scaffold compounds themselves, and the purine adduct may have applications as a 2 '-deoxyadenosine isostere. We anticipate additional benefits, implied by their structures, in metabolic stability and reduced toxicity of the isoidide conjugates as well.
引用
收藏
页码:176 / 182
页数:7
相关论文
共 50 条
  • [1] Incorporation of an Isohexide Subunit into the Endochin-like Quinolone Scaffold
    Senkina, Julia
    Knapp, Spencer
    MOLECULES, 2024, 29 (15):
  • [2] Acrylamide Functional Group Incorporation Improves Drug-like Properties: An Example with EGFR Inhibitors
    Wu, Kuen-Da
    Chen, Grace Shiahuy
    Liu, Jia-Rong
    Hsieh, Chen-En
    Chern, Ji-Wang
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (01): : 22 - 26
  • [3] Drug delivery for bioactive polysaccharides to improve their drug-like properties and curative efficacy
    Li, Zhe
    Wang, Lina
    Lin, Xiao
    Shen, Lan
    Feng, Yi
    DRUG DELIVERY, 2017, 24 (02) : 70 - 80
  • [4] Drug-like index: A new approach to measure drug-like compounds and their diversity
    Xu, J
    Stevenson, J
    JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2000, 40 (05): : 1177 - 1187
  • [5] Improving the odds in discriminating "Drug-like" from "Non Drug-like" compounds
    Frimurer, TM
    Bywater, R
    Nærum, L
    Lauritsen, LN
    Brunak, S
    JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2000, 40 (06): : 1315 - 1324
  • [6] Historeceptomic Fingerprints for Drug-Like Compounds
    Shmelkov, Evgeny
    Grigoryan, Arsen
    Swetnam, James
    Xin, Junyang
    Tivon, Doreen
    Shmelkov, Sergey V.
    Cardozo, Timothy
    FRONTIERS IN PHYSIOLOGY, 2015, 6
  • [7] Selection criteria for drug-like compounds
    Muegge, I
    MEDICINAL RESEARCH REVIEWS, 2003, 23 (03) : 302 - 321
  • [8] Prediction of the Corneal Permeability of Drug-Like Compounds
    Heidi Kidron
    Kati-Sisko Vellonen
    Eva M. del Amo
    Anita Tissari
    Arto Urtti
    Pharmaceutical Research, 2010, 27 : 1398 - 1407
  • [9] Prediction of the Corneal Permeability of Drug-Like Compounds
    Kidron, Heidi
    Vellonen, Kati-Sisko
    del Amo, Eva M.
    Tissari, Anita
    Urtti, Arto
    PHARMACEUTICAL RESEARCH, 2010, 27 (07) : 1398 - 1407
  • [10] Recognizing molecules with drug-like properties
    Walters, WP
    Murcko, A
    Murcko, MA
    CURRENT OPINION IN CHEMICAL BIOLOGY, 1999, 3 (04) : 384 - 387